Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$886M |
| 2 |
Chevron
CVX
|
+$595M |
| 3 |
Union Pacific
UNP
|
+$360M |
| 4 |
Baxter International
BAX
|
+$276M |
| 5 |
Xcel Energy
XEL
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$520M |
| 2 |
NXP Semiconductors
NXPI
|
+$248M |
| 3 |
Oracle
ORCL
|
+$242M |
| 4 |
Amgen
AMGN
|
+$197M |
| 5 |
Eli Lilly
LLY
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.12% |
| 2 | Technology | 7.86% |
| 3 | Healthcare | 6.8% |
| 4 | Industrials | 5.01% |
| 5 | Consumer Discretionary | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EOSEW
3701
CALL
Eos Energy Enterprises Warrant
EOSEW
$27.7M
| $1.95M | ﹤0.01% |
4,628,839
-21,161
| -0.5% | -$9.78K |
|
|
JMAC
3702
DELISTED
Maxpro Capital Acquisition Corp. Class A Common Stock
JMAC
| $1.94M | ﹤0.01% |
192,671
| – | – |
|
|
CMRC
3703
Commerce.com Inc Series 1
CMRC
$281M
| $1.94M | ﹤0.01% |
+131,144
| New | +$2.25M |
|
3704
Advantage Solutions
ADV
$439M
| $1.94M | ﹤0.01% |
36,409
+25,721
| +241% | +$2.37M |
|
|
PR
3705
Permian Resources
PR
$16.6B
| $1.94M | ﹤0.01% |
284,849
-4,269,476
| -94% | -$29.5M |
|
3706
United Bankshares
UBSI
$6.72B
| $1.93M | ﹤0.01% |
54,006
-73,555
| -58% | -$2.74M |
|
3707
Piper Sandler
PIPR
$5.14B
| $1.93M | ﹤0.01% |
+73,716
| New | +$2.15M |
|
|
DBD
3708
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.93M | ﹤0.01% |
790,600
-557,719
| -41% | -$1.86M |
|
|
AMRN
3709
Amarin Corp
AMRN
$304M
| $1.92M | ﹤0.01% |
88,276
-39,065
| -31% | -$1.05M |
|
|
TPH
3710
DELISTED
Tri Pointe Homes
TPH
| $1.92M | ﹤0.01% |
127,357
-104,329
| -45% | -$1.84M |
|
3711
Cullinan Oncology
CGEM
$1.08B
| $1.92M | ﹤0.01% |
149,407
-172,277
| -54% | -$2.32M |
|
|
TE
3712
T1 Energy
TE
$1.53B
| $1.91M | ﹤0.01% |
134,379
-173,774
| -56% | -$1.94M |
|
|
INTE
3713
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
| $1.91M | ﹤0.01% |
193,357
+11,357
| +6% | +$113K |
|
|
TDCX
3714
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $1.91M | ﹤0.01% |
204,271
+145,323
| +247% | +$1.27M |
|
3715
Voyager Therapeutics
VYGR
$187M
| $1.91M | ﹤0.01% |
322,875
-505,921
| -61% | -$3.24M |
|
3716
PMV Pharmaceuticals
PMVP
$62.4M
| $1.91M | ﹤0.01% |
+160,496
| New | +$2.32M |
|
3717
Cohen & Steers
CNS
$4.33B
| $1.9M | ﹤0.01% |
30,385
-23,386
| -43% | -$1.67M |
|
3718
State Street SPDR S&P Dividend ETF
SDY
$23.8B
| $1.9M | ﹤0.01% |
+17,055
| New | +$2.1M |
|
3719
Astrana Health
ASTH
$1.77B
| $1.9M | ﹤0.01% |
48,735
-39,452
| -45% | -$1.81M |
|
3720
Garrett Motion
GTX
$5.86B
| $1.9M | ﹤0.01% |
336,229
+149,196
| +80% | +$1.02M |
|
3721
PetMed Express
PETS
$42.1M
| $1.9M | ﹤0.01% |
97,175
-153,755
| -61% | -$3.26M |
|
|
YALA
3722
Yalla Group
YALA
$815M
| $1.89M | ﹤0.01% |
584,113
+350,858
| +150% | +$1.43M |
|
3723
Belden
BDC
$5.01B
| $1.89M | ﹤0.01% |
31,509
+20,797
| +194% | +$1.32M |
|
|
SEM
3724
DELISTED
Select Medical
SEM
| $1.89M | ﹤0.01% |
158,558
-10,377
| -6% | -$147K |
|
3725
PUT
Range Resources
RRC
$8.91B
| $1.89M | ﹤0.01% |
74,700
-161,500
| -68% | -$4.88M |
|
Similar funds
Millennium Management's Q3 2022 Portfolio in Review
As of Q3 2022, Millennium Management held 7,917 positions worth $169B, up 4.9% from $161B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $14.7B of net new capital in Q3 2022, opening 1,007 new positions and adding to 2,598 existing holdings. Its largest new stake was Rockwell Automation: 953,525 shares worth $205M.
By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 7.6% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $520M trimmed.
- Millennium Management's largest Q3 2022 buy was Rockwell Automation: 953,525 shares worth $205M.
- Millennium Management added most to Duke Realty Corp. in Q3 2022, an estimated $886M increase.
- Millennium Management's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $520M.
- Millennium Management fully exited Coherent Inc in Q3 2022, selling an estimated $114M.
- Millennium Management's ten largest holdings make up 23% of its $169B portfolio in Q3 2022.
- Millennium Management opened 1,007 new positions and closed 906 in Q3 2022.
- Millennium Management's portfolio value rose 4.9% quarter-over-quarter to $169B.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.